Pacific Biosciences Of California (PACB) Net Shares Issued and Repurchased (2013 - 2022)

Pacific Biosciences Of California has reported Net Shares Issued and Repurchased for 10 years, with the latest figure at $5.2 million in Q4 2022.

• On a quarterly basis, Net Shares Issued and Repurchased rose 863.22% year-over-year to $5.2 million in Q4 2022; TTM through Dec 2022 was $5.2 million, a 863.22% increase from a year earlier, with the FY2022 full-year figure at $5.2 million, up 863.22% from the prior year.
• Net Shares Issued and Repurchased was $5.2 million for Q4 2022 at Pacific Biosciences Of California, up from $322000.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $5.2 million in Q4 2022, with the low at $292000.0 in Q1 2018.
• Average Net Shares Issued and Repurchased over 5 years is $1.5 million, with a median of $761000.0 recorded in 2019.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased slumped 80.9% in 2021, then soared 863.22% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.7 million in 2018, then slumped by 52.8% to $1.3 million in 2019, then surged by 121.33% to $2.8 million in 2020, then plunged by 80.9% to $541000.0 in 2021, then jumped by 863.22% to $5.2 million in 2022.
• The last three Net Shares Issued and Repurchased figures came in at $5.2 million (Q4 2022), $322000.0 (Q1 2022), and $541000.0 (Q4 2021), per Business Quant data.